Connect with:
Friday / December 20. 2024

logo
mobile-logo
HomePosts Tagged "cannabis"
Company News, Seeds, World

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21 per cent and four high-THC strains in the 30-35 per cent range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Cream pop. These selections represent the top .01 per cent of HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

Apollo Green to distribute Humboldt Seed Company clonal

AgroPolicy, Horticulture, India, R&D, Sustainability

Dr Jitendra Singh chairs the review meeting of the Cannabis Research Project of CSIR-IIIM at Jammu

‘Cannabis Research Project’ of CSIR-IIIM Jammu is a first of its kind in India which has great potential to produce and export quality medicine for neuropathies, cancer & epilepsy, Dr Jitendra Singh, Union Minister of State (Independent Charge) Science & Technology;  said this while chairing a review meeting with the top officials of CSIR-IIIM and J&K UT Science and Technology Department.

During the meeting, Dr Jitendra Singh said, the signing of a scientific agreement between CSIR-IIIM and IndusScan was historic not only for J&K but for the whole of India as it has the potential to produce those kinds of medicines which have to be exported from foreign countries. This kind of project will give an impetus for huge investment in Jammu and Kashmir, Dr Singh added.

While appreciating CSIR-IIIM for this project, Dr Jitendra Singh said, CSIR-IIIM is the oldest scientific research institute in India with a history of discovering the mint way back in the 1960s, the centre of purple revolution and now the Cannabis Research Project of CSIR-IIIM is going to make it more prestigious in terms of scientific research in India.

Dr. Jitendra Singh further said, for such a kind of important project, synergy between institutions like CSIR-IIIM, IIM, IIT, AIIMS etc. is imperative to look for various technicalities involved in it like the marketing strategies that can be done through IIM, clinical trials through AIIMS, technical support through IIT etc. as all these institutions are only situated in a radius of few kilometres in Jammu which is now the hub of education in India.

Dr Jitendra Singh chairs the review meeting

Agrotech, Company News, Sustainability, World

A breeder-centric hub of new cannabis clone genetics, carefully propagated in small batches and available only to select, hand-picked California growers

Phinest Cannabis, California’s leading provider of cannabis tissue culture-based clones and operator of one of North America’s largest indoor cannabis clone nurseries announced the introduction of a new project called Dubplatez.

Dubplatez is an initiative by the Phinest team to reverse the recent trend of cannabis genetics being bred for a very narrow range of attributes that are currently in demand by distributors and brokers.

“Botanists have identified more than 100 cannabinoids in cannabis and 400 different terpenes,” said Matt Wich, COO for Phinest Cannabis. “We have more than 200 distinct aroma compounds to work with. The combination of these elements should provide breeders with a nearly infinite palette to explore. Yet we continue to see a hyper-focus on high THC production and on purple strains which is driving the industry toward the lowest common denominator genetics. Dubplatez is our commitment to change this direction.”

Ian Strouss, VP of Breeding and Cultivation for Phinest states, “Dubplatez is the underground label for cultivators who want something truly unique. By taking chances, the farmers will be able to earn higher tickets on unique genetics. High risk, high reward. Our approach is to follow in the footsteps of heirloom/craft movements in other industries. We want to experiment with all the flavours, smells and effects of cannabis in order to create more beautiful expressions from the plant. We’re in the trenches looking, smelling and smoking original work being created by new breeders with passion and skill.”

A breeder-centric hub of new cannabis clone

Company News, India, R&D

India’s premier research institute IIT-Kanpur has inked a Memorandum of Understanding (MoU) with Niche Agriculture & Pharmaceuticals Limited (NAPL), a company engaged in agricultural activities and formulation of advanced medicines, for research on cultivation of ‘Cannabis’ and its usage in pharma and bioengineering. The collaboration will focus on research, development, and consultancy studies in the fields of mutual interest.

By partnering together, the two organisations are setting the groundwork for reorganising the indigenous cannabis plant and creating new hemp cultivars that adhere to international regulations. The development of new hemp-based treatments will help doctors address the rising rates of cancer, epilepsy, migraine, chronic pain, arthritis, and insomnia in India.

The MoU was signed by Professor Abhay Karandikar, Director, IIT Kanpur and Harisharan Devgan, Chairman of Niche Group of Companies, in the presence of senior professors, researchers, and other faculty members. Speaking on the partnership, Karandikar said that it will lay the foundation for better research and development in the biotech industry. “Cannabis has been widely accepted in Indian culture through the ages, yet we have limited knowledge about this holy plant,” he further added.

Elaborating on the MoU, Devgan said, “This collaboration will not only grant access to a whole new range of medicinal formulations, but it will also offer people affordable medical treatment for chronic health problems. We are focusing on improving cooperation in the field of hemp cultivation and bioengineering and implementing technologies like tissue culture with IIT-Kanpur for research and development, and exchanging academic materials and publications for the formulation of hemp-based and other medicines for chronic diseases.”

India’s premier research institute IIT-Kanpur has inked

Company News

The New Facility enables a 30x increase in production capacity from Phinest’s original facility and incorporates state-of-the-art design and construction

Green Stripes Services, LLC (Phinest Cannabis), announces the opening of a new 40,000 ft² cannabis tissue culture and indoor nursery facility in Sacramento, CA to meet growing demand for pathogen-free cannabis nursery stock for the California cannabis industry. The New Facility was built by GCI – Green Capital Investments, LLC.

The New Facility enables a 30x increase in production capacity from Phinest’s original facility and incorporates state-of-the-art design and construction. The New Facility is capable of producing upwards of 15 million fully rooted cannabis plants yearly. Fred Barnum (Managing Member of the Developer) states, “The New Facility represents the future of tissue culture nursery operations. It is purpose-built, creating an environment that supports high phytosanitary standards to deliver the healthiest and most vigorous plants to licensed California cultivators and retailers.

“The New Facility includes space for tissue culture micropropagation production, rooting and hardening of plantlets, and research and development. Matthew Wich (COO for the Company) says, “Every aspect of the New Facility upholds the quality that has built Phinest’s reputation as a leading cannabis nursery operator. For our breeding and genetics partners, the New Facility provides a platform that delivers the best expressions of their work to the largest customer base.”

The New Facility enables a 30x increase